{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:34:19Z","timestamp":1793651659490,"version":"4.5.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,10,19]],"date-time":"2012-10-19T00:00:00Z","timestamp":1350604800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s00774-012-0393-x","type":"journal-article","created":{"date-parts":[[2012,10,31]],"date-time":"2012-10-31T14:25:01Z","timestamp":1351693501000},"page":"153-160","source":"Crossref","is-referenced-by-count":26,"title":["A comparative study of the effects of daily minodronate and weekly alendronate on upper gastrointestinal symptoms, bone resorption, and back pain in postmenopausal osteoporosis patients"],"prefix":"10.1007","volume":"31","author":[{"given":"Toru","family":"Yoshioka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobukazu","family":"Okimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,19]]},"reference":[{"key":"393_CR1","first-page":"233","volume":"6","author":"AD Anastasilakis","year":"2007","unstructured":"Anastasilakis AD, Goulis DG, Kita M, Avramidis A (2007) Oral bisphosphonate adverse effects in 849 patients with metabolic bone diseases. Hormones 6:233\u2013341","journal-title":"Hormones"},{"key":"393_CR2","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1185\/03007991003633603","volume":"26","author":"C Woo","year":"2010","unstructured":"Woo C, Gao G, Wade S, Hochberg MC (2010) Gastrointestinal side effects in postmenopausal women using osteoporosis therapy: 1-year findings in the POSSIBLE US study. Curr Med Res Opin 26:1003\u20131009","journal-title":"Curr Med Res Opin"},{"key":"393_CR3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00198-002-1370-3","volume":"14","author":"B Hamilton","year":"2003","unstructured":"Hamilton B, McCoy K, Taggart H (2003) Tolerability and compliance with risedronate in clinical practice. Osteoporos Int 14:259\u2013262","journal-title":"Osteoporos Int"},{"key":"393_CR4","first-page":"1965","volume":"29","author":"AB Thomson","year":"2002","unstructured":"Thomson AB, Marshall JK, Hunt RH, Provenza JM, Lanza FL, Royer MG, Li Z, Blank MA, Risedronate Endoscopy Study Group (2002) 14\u00a0day endoscopy study comparing risedronate and alendronate in postmenopausal women stratified by Helicobacter pylori status. J Rheumatol 29:1965\u20131974","journal-title":"J Rheumatol"},{"key":"393_CR5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1053\/gast.2000.16517","volume":"119","author":"FL Lanza","year":"2000","unstructured":"Lanza FL, Hunt RH, Thomas AB, Provenza JM, Blank MA (2000) Endoscopic comparison of esophageal and gastroduodenal effects of risedronate and alendronate in postmenopausal women. Gastroenterology 119:631\u2013638","journal-title":"Gastroenterology"},{"key":"393_CR6","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00198-008-0816-7","volume":"20","author":"T Matsumoto","year":"2009","unstructured":"Matsumoto T, Hagino H, Shiraki M, Fukunaga M, Nakano T, Takaoka K, Morii H, Ohashi Y, Nakamura T (2009) Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study. Osteoporos Int 20:1429\u20131437","journal-title":"Osteoporos Int"},{"key":"393_CR7","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00774-009-0138-7","volume":"28","author":"M Ito","year":"2009","unstructured":"Ito M, Sone T, Fukunaga M (2009) Effect of minodronic acid hydrate on hip geometry in Japanese women with postmenopausal osteoporosis. J Bone Miner Metab 28:334\u2013341","journal-title":"J Bone Miner Metab"},{"key":"393_CR8","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.bone.2009.02.016","volume":"44","author":"H Hagino","year":"2009","unstructured":"Hagino H, Nishizawa Y, Sone T, Morii H, Taketani Y, Nakamura T, Itabashi A, Mizunuma H, Ohashi Y, Shiraki M, Minamide T, Matsumoto T (2009) A double-blinded head-to-head trial of minodronate and alendronate in women with postmenopausal osteoporosis. Bone 44:1078\u20131084","journal-title":"Bone"},{"key":"393_CR9","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.2169\/internalmedicine.50.5390","volume":"50","author":"E Kakuta","year":"2011","unstructured":"Kakuta E, Yamashita N, Katsube T, Kushiyama Y, Suetsugu H, Furuta K, Kinoshita Y (2011) Abdominal symptom-related QOL in individuals visiting an outpatient clinic and those attending an annual health check. Intern Med 50:1517\u20131522","journal-title":"Intern Med"},{"key":"393_CR10","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.2169\/internalmedicine.50.5678","volume":"50","author":"Y Kinoshita","year":"2011","unstructured":"Kinoshita Y, Chiba T, The FUTURE Study Group (2011) Characteristics of Japanese patients with chronic gastritis and comparison with functional dyspepsia defined by ROME III criteria: based on the large-scale survey, FUTURE Study. Intern Med 50:2269\u20132276","journal-title":"Intern Med"},{"key":"393_CR11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s007740050038","volume":"16","author":"H Orimo","year":"1998","unstructured":"Orimo H, Sugioka Y, Fukunaga M, Muto M, Hotokebuchi T, Gorai I, Nakamura T, Kushida K, Tanaka H, Ikai T, Oh-hashi Y (1998) Diagnostic criteria of primary osteoporosis. J Bone Miner Metab 16:139\u2013150","journal-title":"J Bone Miner Metab"},{"key":"393_CR12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s007740170001","volume":"19","author":"H Orimo","year":"2001","unstructured":"Orimo H, Hayashi Y, Fukunaga M, Sone T, Fujiwara S, Shiraki M, Kushida K, Miyamoto S, Soen S, Nishimura J, Oh-hashi Y, Hosoi T, Gorai I, Tanaka H, Igai T, Kishimoto H, Osteoporosis Diagnostic Criteria Review Committee, Japanese Society for Bone Mineral Research (2001) Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab 19:331\u2013337","journal-title":"J Bone Miner Metab"},{"key":"393_CR13","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","volume":"8","author":"HK Genant","year":"1993","unstructured":"Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137\u20131148","journal-title":"J Bone Miner Res"},{"key":"393_CR14","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00774-003-0457-z","volume":"22","author":"M Fukunaga","year":"2004","unstructured":"Fukunaga M, Nakamura T, Shiraki M, Kuroda T, Ohta H, Hosoi T, Orimo H (2004) Absolute height reduction and percent height ratio of the vertebral body in incident fracture in Japanese women. J Bone Miner Metab 22:104\u2013110","journal-title":"J Bone Miner Metab"},{"key":"393_CR15","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1023\/A:1018894827961","volume":"43","author":"CP Peter","year":"1998","unstructured":"Peter CP, Handt LK, Smith SM (1998) Esophageal irritation due to alendronate sodium tablets: possible mechanisms. Dig Dis Sci 43:1998\u20132002","journal-title":"Dig Dis Sci"},{"key":"393_CR16","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1023\/A:1018826600877","volume":"43","author":"CP Peter","year":"1998","unstructured":"Peter CP, Kindt MV, Majka JA (1998) Comparative study of potential for bisphosphonates to damage gastric mucosa of rats. Dig Dis Sci 43:1009\u20131015","journal-title":"Dig Dis Sci"},{"key":"393_CR17","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1023\/A:1005574009856","volume":"45","author":"LM Lichtenberger","year":"2000","unstructured":"Lichtenberger LM, Romero JJ, Gibson GW, Blank MA (2000) Effect of bisphosphonate on surface hydrophobicity and phosphatidylcholine concentration of rodent gastric mucosa. Dig Dis Sci 45:1792\u20131801","journal-title":"Dig Dis Sci"},{"key":"393_CR18","first-page":"1478","volume":"106","author":"K Furuta","year":"2009","unstructured":"Furuta K, Ishihara S, Sato S, Miyake T, Ishimura N, Koshino K, Tobita H, Moriyama I, Amano Y, Adachi K, Ohta A, Kinoshita Y (2009) Development and verification of the Izumo Scale, new questionnaire for quality of life assessment of patients with gastrointestinal symptoms. Nihon Shokakibyo Gakkai Zasshi 106:1478\u20131487 (in Japanese)","journal-title":"Nihon Shokakibyo Gakkai Zasshi"},{"key":"393_CR19","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1056\/NEJM199610033351403","volume":"335","author":"PC Groen","year":"1996","unstructured":"Groen PC, Lubbe DF, Hirsch LJ, Daifotis A, Stephenson W, Freedholm D, Pryor-Tillotson S, Seleznick MJ, Pinkas H, Wang KK (1996) Esophagitis associated with the use of alendronate. N Engl J Med 335:1016\u20131021","journal-title":"N Engl J Med"},{"key":"393_CR20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0378-5173(01)00722-0","volume":"222","author":"AC Perkins","year":"2001","unstructured":"Perkins AC, Wilson CG, Frier M, Blackshaw PE, Dansereau RJ, Vincent RM, Wenderoth D, Hathaway S, Li Z, Spiller RC (2001) The use of scintigraphy to demonstrate the rapid esophageal transit of the oval film-coated placebo risedronate tablet compared to a round uncoated placebo tablet when administered with minimal volumes water. Int J Pharm 222:295\u2013303","journal-title":"Int J Pharm"},{"key":"393_CR21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00774-006-0706-z","volume":"24","author":"H Kishimoto","year":"2006","unstructured":"Kishimoto H, Fukunaga M, Kushida K, Shiraki M, Itabashi A, Nawata H, Nakamura T, Ohta H, Takaoka K, Ohashi Y, Risedronate Phase III Research Group (2006) Efficacy and tolerability of once-weekly administration of 17.5\u00a0mg risedronate in Japanese patients with involutional osteoporosis; a comparison with 2.5\u00a0mg once-daily dosage regimen. J Bone Miner Metab 24:405\u2013413","journal-title":"J Bone Miner Metab"},{"key":"393_CR22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1742-1241.2001.tb11111.x","volume":"55","author":"N Dursun","year":"2001","unstructured":"Dursun N, Dursun E, Yalcin S (2001) Comparison of alendronate, calcitonin and calcium treatment in postmenopausal osteoporosis. Int J Clin Pract 55:505\u2013509","journal-title":"Int J Clin Pract"},{"key":"393_CR23","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10067-004-0881-z","volume":"23","author":"J Iwamoto","year":"2004","unstructured":"Iwamoto J, Takeda T, Sato Y, Uzawa M (2004) Effects of alendronate on metacarpal and lumbar bone mineral density, bone resorption, and chronic back pain in postmenopausal women with osteoporosis. Clin Rheumatol 23:383\u2013389","journal-title":"Clin Rheumatol"},{"key":"393_CR24","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejphar.2008.05.011","volume":"589","author":"S Kakimoto","year":"2008","unstructured":"Kakimoto S, Nagakura Y, Tamura S, Watabiki T, Shibasaki K, Tanaka S, Mori M, Sasamata M, Okada M (2008) Minodronic acid, a third-generation bisphosphonate, antagonizes purinergic P2X2\/3 receptor function and exerts an analgesic effect in pain models. Eur J Pharmacol 589:98\u2013101","journal-title":"Eur J Pharmacol"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-012-0393-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-012-0393-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-012-0393-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T22:59:18Z","timestamp":1714517958000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-012-0393-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,19]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["393"],"URL":"https:\/\/doi.org\/10.1007\/s00774-012-0393-x","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,19]]}}}